• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于癌症光动力治疗的活性氧（ROS）响应型药物递送系统的最新进展

Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer.

作者信息

Hu Danrong, Li Yicong, Li Ran, Wang Meng, Zhou Kai, He Chengqi, Wei Quan, Qian Zhiyong

机构信息

Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Acta Pharm Sin B. 2024 Dec;14(12):5106-5131. doi: 10.1016/j.apsb.2024.10.015. Epub 2024 Nov 2.

DOI:10.1016/j.apsb.2024.10.015
PMID:39807318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11725102/
Abstract

Reactive oxygen species (ROS)-responsive drug delivery systems (DDSs) have garnered significant attention in cancer research because of their potential for precise spatiotemporal drug release tailored to high ROS levels within tumors. Despite the challenges posed by ROS distribution heterogeneity and endogenous supply constraints, this review highlights the strategic alliance of ROS-responsive DDSs with photodynamic therapy (PDT), enabling selective drug delivery and leveraging PDT-induced ROS for enhanced therapeutic efficacy. This review delves into the biological importance of ROS in cancer progression and treatment. We elucidate in detail the operational mechanisms of ROS-responsive linkers, including thioether, thioketal, selenide, diselencide, telluride and aryl boronic acids/esters, as well as the latest developments in ROS-responsive nanomedicines that integrate with PDT strategies. These insights are intended to inspire the design of innovative ROS-responsive nanocarriers for enhanced cancer PDT.

摘要

活性氧（ROS）响应型药物递送系统（DDSs）因其能够针对肿瘤内高ROS水平进行精确的时空药物释放，在癌症研究中备受关注。尽管ROS分布异质性和内源性供应限制带来了挑战，但本综述强调了ROS响应型DDSs与光动力疗法（PDT）的战略联盟，实现了选择性药物递送，并利用PDT诱导的ROS提高治疗效果。本综述深入探讨了ROS在癌症进展和治疗中的生物学重要性。我们详细阐述了ROS响应型连接子的作用机制，包括硫醚、硫缩酮、硒化物、二硒化物、碲化物和芳基硼酸/酯，以及与PDT策略相结合的ROS响应型纳米药物的最新进展。这些见解旨在启发设计创新的ROS响应型纳米载体，以增强癌症PDT效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/0abaa0e19014/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/587ca412bec7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/c7ea6343cfdf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/1f72830ef277/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/e93231abb196/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/6b4d5963b36a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/527b0dfc1111/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/7a04667db7ea/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/e42377b432c4/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/479c43e11951/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/7cf3c7b7e724/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/a3ebd8bba4e7/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/0abaa0e19014/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/587ca412bec7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/c7ea6343cfdf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/1f72830ef277/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/e93231abb196/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/6b4d5963b36a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/527b0dfc1111/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/7a04667db7ea/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/e42377b432c4/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/479c43e11951/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/7cf3c7b7e724/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/a3ebd8bba4e7/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db8b/11725102/0abaa0e19014/gr11.jpg

相似文献

1
Recent advances in reactive oxygen species (ROS)-responsive drug delivery systems for photodynamic therapy of cancer.用于癌症光动力治疗的活性氧（ROS）响应型药物递送系统的最新进展
Acta Pharm Sin B. 2024 Dec;14(12):5106-5131. doi: 10.1016/j.apsb.2024.10.015. Epub 2024 Nov 2.
2
[Reactive oxygen species stimuli-responsive nanocarriers].[活性氧物种刺激响应性纳米载体]
Se Pu. 2021 Feb;39(2):118-124. doi: 10.3724/SP.J.1123.2020.11014.
3
Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.用于化学-光动力治疗的生物激活型活性氧敏感纳米颗粒系统。
Acta Biomater. 2020 May;108:273-284. doi: 10.1016/j.actbio.2020.03.027. Epub 2020 Mar 21.
4
Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.用于活性氧介导方法的纳米医学：癌症治疗的新兴范例。
Acc Chem Res. 2019 Jul 16;52(7):1771-1782. doi: 10.1021/acs.accounts.9b00136. Epub 2019 Jun 26.
5
Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.基于 ROS 响应性聚合物纳米载体的化学-光动力治疗级联放大协同效应。
Theranostics. 2018 Apr 18;8(11):2939-2953. doi: 10.7150/thno.24015. eCollection 2018.
6
ROS-responsive self-assembly nanoplatform overcomes hypoxia for enhanced photodynamic therapy.ROS 响应自组装纳米平台克服缺氧以增强光动力疗法。
Biomater Sci. 2024 Sep 25;12(19):5105-5114. doi: 10.1039/d4bm00712c.
7
Oxygen-supplying ROS-responsive prodrug for synergistic chemotherapy and photodynamic therapy of colon cancer.用于结肠癌协同化疗和光动力治疗的供氧ROS响应前药
Front Pharmacol. 2024 Feb 14;15:1325544. doi: 10.3389/fphar.2024.1325544. eCollection 2024.
8
ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.载有 NIR 光触发阿霉素释放的 ROS 响应脂质体用于乳腺癌的联合治疗。
J Nanobiotechnology. 2021 May 11;19(1):134. doi: 10.1186/s12951-021-00877-6.
9
ROS-responsive drug delivery systems.活性氧响应型药物递送系统
Bioeng Transl Med. 2016 Jul 5;1(3):239-251. doi: 10.1002/btm2.10014. eCollection 2016 Sep.
10
Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers.用于无线控制光动力疗法治疗前列腺癌的光响应智能纳米载体。
Acta Biomater. 2023 Nov;171:553-564. doi: 10.1016/j.actbio.2023.09.031. Epub 2023 Sep 20.

引用本文的文献

1
Modulation of Redox-Sensitive Cardiac Ion Channels.氧化还原敏感型心脏离子通道的调节
Antioxidants (Basel). 2025 Jul 8;14(7):836. doi: 10.3390/antiox14070836.
2
Harnessing the interaction between redox signaling and senescence to restrain tumor drug resistance.利用氧化还原信号与衰老之间的相互作用来抑制肿瘤耐药性。
Front Cell Dev Biol. 2025 Jul 9;13:1639772. doi: 10.3389/fcell.2025.1639772. eCollection 2025.
3
Biomaterials nanoplatform-based tumor vaccines for immunotherapy.基于生物材料纳米平台的肿瘤免疫治疗疫苗

本文引用的文献

1
A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.一种自扩增的 ROS 响应型纳米平台，用于同时实现铜死亡和癌症免疫治疗。
Adv Sci (Weinh). 2024 Jun;11(23):e2401047. doi: 10.1002/advs.202401047. Epub 2024 Apr 3.
2
Immune cells: potential carriers or agents for drug delivery to the central nervous system.免疫细胞：递送至中枢神经系统药物的潜在载体或载体。
Mil Med Res. 2024 Mar 29;11(1):19. doi: 10.1186/s40779-024-00521-y.
3
Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy.
Bioact Mater. 2025 Jun 30;51:924-961. doi: 10.1016/j.bioactmat.2025.06.038. eCollection 2025 Sep.
4
Improvement of the Anticancer Efficacy of PD-1/PD-L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies.PD-1/PD-L1阻断疗法抗癌疗效的改善：分子机制与治疗策略的进展
MedComm (2020). 2025 Jul 15;6(8):e70274. doi: 10.1002/mco2.70274. eCollection 2025 Aug.
5
Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities.氧化应激与炎症：肿瘤发生的驱动因素及治疗机遇
Antioxidants (Basel). 2025 Jun 15;14(6):735. doi: 10.3390/antiox14060735.
6
Dual-organelle targeted photosensitizer with AIE characteristics for triple-negative breast cancer photodynamic therapy via apoptosis and immunogenic cell death.具有聚集诱导发光特性的双细胞器靶向光敏剂用于三阴性乳腺癌的光动力治疗：通过细胞凋亡和免疫原性细胞死亡
Mater Today Bio. 2025 May 4;32:101828. doi: 10.1016/j.mtbio.2025.101828. eCollection 2025 Jun.
7
Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer.活性氧：从肿瘤发生到癌症治疗策略
Cancer Med. 2025 May;14(10):e70947. doi: 10.1002/cam4.70947.
8
Antioxidants in cancer therapy mitigating lipid peroxidation without compromising treatment through nanotechnology.癌症治疗中的抗氧化剂通过纳米技术减轻脂质过氧化而不影响治疗效果。
Discov Nano. 2025 Apr 24;20(1):70. doi: 10.1186/s11671-025-04248-0.
9
Thioether Oxidation Chemistry in Reactive Oxygen Species (ROS)-Sensitive Trigger Design: A Kinetic Analysis.活性氧（ROS）敏感触发设计中的硫醚氧化化学：动力学分析
Org Lett. 2025 Mar 28;27(12):3071-3076. doi: 10.1021/acs.orglett.5c00747. Epub 2025 Mar 19.
具有超低功率近红外光激发的氧非依赖型有机光动力剂用于肿瘤特异性光动力治疗。
Nat Commun. 2024 Mar 21;15(1):2530. doi: 10.1038/s41467-024-46768-w.
4
Metal nanoparticles for cancer therapy: Precision targeting of DNA damage.用于癌症治疗的金属纳米颗粒：DNA损伤的精准靶向
Acta Pharm Sin B. 2024 Mar;14(3):1132-1149. doi: 10.1016/j.apsb.2023.08.031. Epub 2023 Sep 3.
5
Small-molecule agents for cancer immunotherapy.用于癌症免疫治疗的小分子药物。
Acta Pharm Sin B. 2024 Mar;14(3):905-952. doi: 10.1016/j.apsb.2023.12.010. Epub 2023 Dec 16.
6
Photodynamic Therapy Induced Mitochondrial Targeting Strategies for Cancer Treatment: Emerging Trends and Insights.光动力疗法诱导的癌症治疗线粒体靶向策略：新趋势与见解
Mol Pharm. 2024 Apr 1;21(4):1591-1608. doi: 10.1021/acs.molpharmaceut.3c01185. Epub 2024 Feb 23.
7
Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.纳米材料诱导的氧化还原失衡：纳米材料在癌症治疗中的挑战与机遇
Adv Sci (Weinh). 2024 Apr;11(16):e2308632. doi: 10.1002/advs.202308632. Epub 2024 Feb 21.
8
Recent Progress in Implantable Drug Delivery Systems.最近在植入式药物输送系统方面的进展。
Adv Mater. 2024 Jun;36(23):e2312530. doi: 10.1002/adma.202312530. Epub 2024 Mar 7.
9
Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy.免疫刺激基因疗法联合检查点阻断重塑肿瘤微环境并增强卵巢癌免疫治疗。
Acta Pharm Sin B. 2024 Feb;14(2):854-868. doi: 10.1016/j.apsb.2023.08.014. Epub 2023 Aug 19.
10
Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy.肿瘤微环境 ROS/pH 级联响应超分子纳米平台，具有 ROS 再生特性，用于增强肝细胞癌治疗。
ACS Appl Mater Interfaces. 2024 Feb 14;16(6):7576-7592. doi: 10.1021/acsami.3c16022. Epub 2024 Feb 5.